Stay updated on Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.
Latest updates to the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2, a minor maintenance/version change that does not affect trial content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check16 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.1; no substantive changes to the page content are observed.SummaryDifference0.1%
- Check23 days agoChange DetectedRemoved the government funding operating status notice from the page; core study details remain unchanged.SummaryDifference0.4%
- Check37 days agoChange DetectedThe updates appear cosmetic and do not affect core trial details such as eligibility criteria, endpoints, or treatment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check66 days agoChange DetectedAdd: government funding notice and open status with external links; Update: version to v3.2.0. Delete: a specific resource entry for small cell lung carcinoma (v3.1.0).SummaryDifference4%
- Check73 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%
Stay in the know with updates to Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.